1. A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of Subjects With Active Crohn’s Disease 
Bruce Yacyshyn, William Y. Chey, Mark K. Wedel, Rosie Z. Yu, David Paul, Emil Chuang 
Clinical Gastroenterology and Hepatology 
Volume 5, Issue 2, Pages (February 2007)
DOI: /j.cgh
Copyright © 2007 AGA Institute Terms and Conditions

2. Figure 1
Relationship between CRP, CumAUC, a measure of exposure to study drug, and probability of achieving clinical remission in subjects who received alicaforsen. Black line represents CRP = 2.0.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh )
Copyright © 2007 AGA Institute Terms and Conditions